Emcure Pharma IPO bids were received for only 29%

The initial public offering (IPO) of Emcure Pharmaceuticals got off to a lukewarm start on July 3rd,

the first day of bidding. Here’s a breakdown of the subscription data.

Overall Subscription Ratio: 0.29 times, meaning bids were received for only 29% of the shares offered.
Non-institutional Investors: Most active category, subscribing to 40% of their allotted quota.
Retail Investors: Subscribed to 38% of their reserved portion.
Employees: Showed the strongest interest, subscribing to 81% of their quota.

Next Post

V-Mart Retail's stock price reached a 52-week high today.

Wed Jul 3 , 2024
V-Mart Retail’s stock price surged on July 3rd, reaching a 52-week high of Rs 3,035, fueled by their positive quarterly update. Here’s a breakdown of the key factors: Strong Revenue Growth: V-Mart Retail’s revenue for Q1 FY25 jumped 16% year-over-year to Rs 790 crore. Healthy Same-Store Sales Growth (SSSG): SSSG […]

You May Like